PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 2 PubMed articles · model: gemma4:31b
Summary
Background
Mechanism of action
Clinical evidence
Borago officinalis leaf extract was studied for its cardioprotective potential and synergistic effect when combined with metoprolol [PMID:41220265].
Silver nanoparticles synthesized using Borago officinalis leaf extract demonstrated anticancer and antibacterial activities [PMID:27598388].
Evidence summary
PubMed sources
- 1.PMID: 41220265 (2025) — Exploring the Cardioprotective Potential of Borago officinalis in Isoproterenol-induced Myocardial Infarction: A Preclinical Study on Rats. · Cardiovascular & hematological disorders drug targets
- 2.PMID: 27598388 (2017) — Green and rapid synthesis of silver nanoparticles using Borago officinalis leaf extract: anticancer and antibacterial activities. · Artificial cells, nanomedicine, and biotechnology